The observation that overexpression of MYCN or of its upstream positive regulator LIN28B targeted to the sympathetic adrenergic lineage of transgenic mice leads to the development of tumors closely resembling human NB [3, 4] supports the hypothesis that MYCN amplification causes NB in humans. Here, MYCN is linked to neuroblastoma.